Cargando…
S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428319/ http://dx.doi.org/10.1097/01.HS9.0000967532.23088.4b |
| _version_ | 1785090439361069056 |
|---|---|
| author | Pfirrmann, Markus Mahon, Francois-Xavier Dulucq, Stéphanie Hochhaus, Andreas Panayiotidis, Panayiotis Almeida, Antonio Mayer, Jiri Hjorth-Hansen, Henrik Janssen, Jeroen J. W. M. Mustjoki, Satu Martinez-Lopez, Joaquín Vestergaard, Hanne Ehrencrona, Hans Kairisto, Veli Machová Poláková, Kateřina Emmanuel Nicolini, Franck Hofmann, Wolf-Karsten Guilhot, Joëlle Saussele, Susanne Richter, Johan |
| author_facet | Pfirrmann, Markus Mahon, Francois-Xavier Dulucq, Stéphanie Hochhaus, Andreas Panayiotidis, Panayiotis Almeida, Antonio Mayer, Jiri Hjorth-Hansen, Henrik Janssen, Jeroen J. W. M. Mustjoki, Satu Martinez-Lopez, Joaquín Vestergaard, Hanne Ehrencrona, Hans Kairisto, Veli Machová Poláková, Kateřina Emmanuel Nicolini, Franck Hofmann, Wolf-Karsten Guilhot, Joëlle Saussele, Susanne Richter, Johan |
| author_sort | Pfirrmann, Markus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428319 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283192023-08-17 S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL Pfirrmann, Markus Mahon, Francois-Xavier Dulucq, Stéphanie Hochhaus, Andreas Panayiotidis, Panayiotis Almeida, Antonio Mayer, Jiri Hjorth-Hansen, Henrik Janssen, Jeroen J. W. M. Mustjoki, Satu Martinez-Lopez, Joaquín Vestergaard, Hanne Ehrencrona, Hans Kairisto, Veli Machová Poláková, Kateřina Emmanuel Nicolini, Franck Hofmann, Wolf-Karsten Guilhot, Joëlle Saussele, Susanne Richter, Johan Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428319/ http://dx.doi.org/10.1097/01.HS9.0000967532.23088.4b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Pfirrmann, Markus Mahon, Francois-Xavier Dulucq, Stéphanie Hochhaus, Andreas Panayiotidis, Panayiotis Almeida, Antonio Mayer, Jiri Hjorth-Hansen, Henrik Janssen, Jeroen J. W. M. Mustjoki, Satu Martinez-Lopez, Joaquín Vestergaard, Hanne Ehrencrona, Hans Kairisto, Veli Machová Poláková, Kateřina Emmanuel Nicolini, Franck Hofmann, Wolf-Karsten Guilhot, Joëlle Saussele, Susanne Richter, Johan S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL |
| title | S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL |
| title_full | S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL |
| title_fullStr | S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL |
| title_full_unstemmed | S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL |
| title_short | S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL |
| title_sort | s155: prognostic factors for 3-year major molecular response maintenance in chronic myeloid leukaemia patients in the european stop kinase inhibitors (euro-ski) trial |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428319/ http://dx.doi.org/10.1097/01.HS9.0000967532.23088.4b |
| work_keys_str_mv | AT pfirrmannmarkus s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT mahonfrancoisxavier s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT dulucqstephanie s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT hochhausandreas s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT panayiotidispanayiotis s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT almeidaantonio s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT mayerjiri s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT hjorthhansenhenrik s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT janssenjeroenjwm s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT mustjokisatu s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT martinezlopezjoaquin s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT vestergaardhanne s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT ehrencronahans s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT kairistoveli s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT machovapolakovakaterina s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT emmanuelnicolinifranck s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT hofmannwolfkarsten s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT guilhotjoelle s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT sausselesusanne s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial AT richterjohan s155prognosticfactorsfor3yearmajormolecularresponsemaintenanceinchronicmyeloidleukaemiapatientsintheeuropeanstopkinaseinhibitorseuroskitrial |